Xiaobing Lan
- Neurology top 10%
- Neuroinflammation and Neurodegeneration Mechanisms 4
-
- Neuropeptides and Animal Physiology 8
- Pharmacology top 10%
- Pharmacological Effects of Natural Compounds 4
-
- Pain Mechanisms and Treatments 7
-
- Neonatal and fetal brain pathology 6
-
- Receptor Mechanisms and Signaling 5
- Histone Deacetylase Inhibitors Research 4
-
- Catalytic C–H Functionalization Methods 3
- Journals
- Biomedicine & Pharmacotherapy (5 papers)Acta Pharmaceutica Sinica B (2 papers)European Journal of Pharmacology (2 papers)
- Partner nations
- ChinaSouth KoreaCanada
In The Last Decade
Xiaobing Lan
40 papers receiving 775 citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Biological Psychiatry 27
- Neurology 83
- Complementary and alternative medicine 49
- Cellular and Molecular Neuroscience 107
- Pharmacology 51
Countries citing papers authored by Xiaobing Lan
This map shows the geographic impact of Xiaobing Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobing Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobing Lan more than expected).
Fields of papers citing papers by Xiaobing Lan
This network shows the impact of papers produced by Xiaobing Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobing Lan. The network helps show where Xiaobing Lan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaobing Lan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 14 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 6 | |
| 7 | 2024 | 14 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 16 | |
| 10 | 2023 | 5 | |
| 11 | 2023 | 9 | |
| 12 | 2023 | 4 | |
| 13 | 2023 | 14 | |
| 14 | 2023 | 9 | |
| 15 | 2023 | 2 | |
| 16 | 2023 | 7 | |
| 17 | 2020 | 15 | |
| 18 | 2020 | 34 | |
| 19 | 2019 | 30 | |
| 20 | 2010 | 43 |
About Xiaobing Lan
Xiaobing Lan is a scholar working on Cellular and Molecular Neuroscience, Neurology and Pharmacology, having authored 42 papers that have together received 777 indexed citations. Recurring topics across this work include Neuropeptides and Animal Physiology (8 papers), Pain Mechanisms and Treatments (7 papers), Neonatal and fetal brain pathology (6 papers), Receptor Mechanisms and Signaling (5 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers), Pharmacological Effects of Natural Compounds (4 papers), Histone Deacetylase Inhibitors Research (4 papers) and Catalytic C–H Functionalization Methods (3 papers). The work is most often cited by research in Biological Psychiatry (27 citations), Neurology (83 citations) and Complementary and alternative medicine (49 citations). Xiaobing Lan has collaborated with scholars based in China, South Korea and Canada. Frequent co-authors include Shaoyong Lu, Xun Lu, Ting Chen, Kai Chen, Jian‐Qiang Yu, Jiamei Yang, Lin Ma, Jianqiang Yu, Jianguo Niu and Tao Sun. Their work appears in journals such as Biomedicine & Pharmacotherapy, Acta Pharmaceutica Sinica B, European Journal of Pharmacology, Organic & Biomolecular Chemistry and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.